ArticlePediatric blood & cancer2021

Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective.

Michael P Triebwasser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.